ESSA Pharma Inc

NASDAQ EPIX

Download Data

ESSA Pharma Inc Asset Coverage Ratio 3 year CAGR for the year ending September 19, 2024

ESSA Pharma Inc Asset Coverage Ratio 3 year CAGR is NA for the year ending September 19, 2024. The asset coverage ratio assesses the extent to which a company's tangible assets can cover its total debt obligations. It is calculated by dividing the difference between total assets and intangible assets by total debt. This ratio provides an indication of a company's ability to repay its debt using its tangible assets. A higher asset coverage ratio suggests a lower financial risk, as the company has a greater cushion of tangible assets to support its debt obligations. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
NASDAQ: EPIX

ESSA Pharma Inc

CEO Dr. David Ross Parkinson M.D.
IPO Date July 9, 2015
Location Canada
Headquarters 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5
Employees 50
Sector Healthcare
Industry Biotechnology
Description

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

StockViz Staff

September 19, 2024

Any question? Send us an email